HEADER HYDROLASE 18-MAY-11 2YJ4 TITLE CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- TITLE 2 B UPON NUCLEOTIDE BINDING COMPND MOL_ID: 1; COMPND 2 MOLECULE: COPPER-TRANSPORTING ATPASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 383-645; COMPND 5 EC: 3.6.1.36, 3.6.3.10; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFOLOBUS SOLFATARICUS; SOURCE 3 ORGANISM_TAXID: 273057; SOURCE 4 STRAIN: P2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET27 KEYWDS HYDROLASE, P-TYPE ATPASE, COPB, HEAVY METAL TRANSLOCATION EXPDTA X-RAY DIFFRACTION AUTHOR C.VOELLMECKE,C.SCHLICKER,M.LUEBBEN,E.HOFMANN REVDAT 2 20-DEC-23 2YJ4 1 REMARK REVDAT 1 30-MAY-12 2YJ4 0 JRNL AUTH C.VOELLMECKE,C.SCHLICKER,M.LUEBBEN,E.HOFMANN JRNL TITL CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE JRNL TITL 2 CPX-ATPASE COPB-B UPON NUCLEOTIDE BINDING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.020 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 21214 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1061 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5811 - 4.7987 0.99 2660 141 0.2112 0.2565 REMARK 3 2 4.7987 - 3.8093 1.00 2553 134 0.1801 0.2152 REMARK 3 3 3.8093 - 3.3279 1.00 2522 133 0.2141 0.2747 REMARK 3 4 3.3279 - 3.0237 1.00 2501 132 0.2438 0.3164 REMARK 3 5 3.0237 - 2.8070 1.00 2505 130 0.2572 0.2901 REMARK 3 6 2.8070 - 2.6415 1.00 2483 131 0.2741 0.3707 REMARK 3 7 2.6415 - 2.5092 1.00 2466 130 0.2755 0.3632 REMARK 3 8 2.5092 - 2.4000 1.00 2463 130 0.2661 0.3397 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.30 REMARK 3 B_SOL : 45.40 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.95420 REMARK 3 B22 (A**2) : -8.99780 REMARK 3 B33 (A**2) : 1.04370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3829 REMARK 3 ANGLE : 1.260 5187 REMARK 3 CHIRALITY : 0.077 632 REMARK 3 PLANARITY : 0.004 647 REMARK 3 DIHEDRAL : 17.945 1417 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YJ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1290048332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21225 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 48.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2IYE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA ACETATE PH 4.5, 0.2 M NA REMARK 280 CHLORIDE, 10% PEG 4000. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.06000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.96000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.57500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.96000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.06000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.57500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 416 TO ASN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASP 416 TO ASN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 383 REMARK 465 ALA A 384 REMARK 465 ASN A 497 REMARK 465 ASN A 498 REMARK 465 ARG A 635 REMARK 465 LYS A 636 REMARK 465 ARG A 637 REMARK 465 LEU A 638 REMARK 465 SER A 639 REMARK 465 ASN A 640 REMARK 465 ALA A 641 REMARK 465 ILE A 642 REMARK 465 PRO A 643 REMARK 465 SER A 644 REMARK 465 ASN A 645 REMARK 465 MET B 383 REMARK 465 LYS B 636 REMARK 465 ARG B 637 REMARK 465 LEU B 638 REMARK 465 SER B 639 REMARK 465 ASN B 640 REMARK 465 ALA B 641 REMARK 465 ILE B 642 REMARK 465 PRO B 643 REMARK 465 SER B 644 REMARK 465 ASN B 645 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 385 CG CD1 CD2 REMARK 470 LYS A 390 CG CD CE NZ REMARK 470 LYS A 399 CG CD CE NZ REMARK 470 GLU A 405 CG CD OE1 OE2 REMARK 470 LYS A 408 CG CD CE NZ REMARK 470 ILE A 479 CG1 CG2 CD1 REMARK 470 LYS A 494 CG CD CE NZ REMARK 470 ASN A 499 CG OD1 ND2 REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 ASP A 525 CG OD1 OD2 REMARK 470 TYR A 526 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 546 CG OD1 OD2 REMARK 470 LYS A 553 CG CD CE NZ REMARK 470 GLN A 558 CG CD OE1 NE2 REMARK 470 ASN A 591 CG OD1 ND2 REMARK 470 ILE A 632 CG1 CG2 CD1 REMARK 470 LYS A 633 CG CD CE NZ REMARK 470 LYS B 471 CG CD CE NZ REMARK 470 LYS B 474 CG CD CE NZ REMARK 470 ILE B 479 CG1 CG2 CD1 REMARK 470 LYS B 484 CG CD CE NZ REMARK 470 ASP B 487 CG OD1 OD2 REMARK 470 GLU B 496 CG CD OE1 OE2 REMARK 470 ASN B 497 CG OD1 ND2 REMARK 470 GLU B 533 CG CD OE1 OE2 REMARK 470 LYS B 553 CG CD CE NZ REMARK 470 GLU B 554 CG CD OE1 OE2 REMARK 470 LYS B 575 CG CD CE NZ REMARK 470 LYS B 633 CG CD CE NZ REMARK 470 ARG B 635 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 400 -171.46 -67.72 REMARK 500 SER A 401 -30.14 -146.88 REMARK 500 LYS A 417 -72.38 -66.04 REMARK 500 SER A 477 -54.45 79.03 REMARK 500 ALA A 495 -94.13 -154.23 REMARK 500 ASN A 522 177.36 148.16 REMARK 500 LEU A 523 -59.70 167.90 REMARK 500 GLU A 533 -137.51 32.76 REMARK 500 ASP A 588 107.46 -177.01 REMARK 500 ASN A 591 3.71 -64.45 REMARK 500 LYS A 633 29.80 -68.93 REMARK 500 GLN B 430 122.45 -172.19 REMARK 500 ALA B 446 -4.51 -56.58 REMARK 500 ILE B 479 -22.77 -145.21 REMARK 500 ASN B 497 -130.36 69.82 REMARK 500 ASN B 522 113.69 90.62 REMARK 500 GLU B 533 8.13 -164.44 REMARK 500 ASP B 588 -67.65 -151.47 REMARK 500 ASN B 623 17.29 56.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AMP A 1635 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 1636 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1636 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IYE RELATED DB: PDB REMARK 900 STRUCTURE OF CATALYTIC CPX-ATPASE DOMAIN COPB-B REMARK 900 RELATED ID: 2YJ5 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING REMARK 900 RELATED ID: 2YJ3 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING REMARK 900 RELATED ID: 2YJ6 RELATED DB: PDB REMARK 900 CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE REMARK 900 COPB-B UPON NUCLEOTIDE BINDING DBREF 2YJ4 A 383 645 UNP Q97UU7 Q97UU7_SULSO 383 645 DBREF 2YJ4 B 383 645 UNP Q97UU7 Q97UU7_SULSO 383 645 SEQADV 2YJ4 ASN A 416 UNP Q97UU7 ASP 416 ENGINEERED MUTATION SEQADV 2YJ4 ASN B 416 UNP Q97UU7 ASP 416 ENGINEERED MUTATION SEQRES 1 A 263 MET ALA LEU SER LEU TYR GLU LYS MET LEU HIS LYS GLY SEQRES 2 A 263 MET ILE ILE LYS ASN SER ASN VAL TYR GLU LYS ILE LYS SEQRES 3 A 263 GLU ILE ASP THR ILE ILE PHE ASN LYS THR GLY THR LEU SEQRES 4 A 263 THR TYR GLY THR PRO ILE VAL THR GLN PHE ILE GLY ASP SEQRES 5 A 263 SER LEU SER LEU ALA TYR ALA ALA SER VAL GLU ALA LEU SEQRES 6 A 263 SER SER HIS PRO ILE ALA LYS ALA ILE VAL LYS TYR ALA SEQRES 7 A 263 LYS GLU GLN GLY VAL LYS ILE LEU GLU VAL LYS ASP PHE SEQRES 8 A 263 LYS GLU ILE SER GLY ILE GLY VAL ARG GLY LYS ILE SER SEQRES 9 A 263 ASP LYS ILE ILE GLU VAL LYS LYS ALA GLU ASN ASN ASN SEQRES 10 A 263 ASP ILE ALA VAL TYR ILE ASN GLY GLU PRO ILE ALA SER SEQRES 11 A 263 PHE ASN ILE SER ASP VAL PRO ARG PRO ASN LEU LYS ASP SEQRES 12 A 263 TYR LEU GLU LYS LEU LYS ASN GLU GLY LEU LYS ILE ILE SEQRES 13 A 263 ILE LEU SER GLY ASP LYS GLU ASP LYS VAL LYS GLU LEU SEQRES 14 A 263 SER LYS GLU LEU ASN ILE GLN GLU TYR TYR SER ASN LEU SEQRES 15 A 263 SER PRO GLU ASP LYS VAL ARG ILE ILE GLU LYS LEU LYS SEQRES 16 A 263 GLN ASN GLY ASN LYS VAL LEU MET ILE GLY ASP GLY VAL SEQRES 17 A 263 ASN ASP ALA ALA ALA LEU ALA LEU ALA ASP VAL SER VAL SEQRES 18 A 263 ALA MET GLY ASN GLY VAL ASP ILE SER LYS ASN VAL ALA SEQRES 19 A 263 ASP ILE ILE LEU VAL SER ASN ASP ILE GLY THR LEU LEU SEQRES 20 A 263 GLY LEU ILE LYS ASN ARG LYS ARG LEU SER ASN ALA ILE SEQRES 21 A 263 PRO SER ASN SEQRES 1 B 263 MET ALA LEU SER LEU TYR GLU LYS MET LEU HIS LYS GLY SEQRES 2 B 263 MET ILE ILE LYS ASN SER ASN VAL TYR GLU LYS ILE LYS SEQRES 3 B 263 GLU ILE ASP THR ILE ILE PHE ASN LYS THR GLY THR LEU SEQRES 4 B 263 THR TYR GLY THR PRO ILE VAL THR GLN PHE ILE GLY ASP SEQRES 5 B 263 SER LEU SER LEU ALA TYR ALA ALA SER VAL GLU ALA LEU SEQRES 6 B 263 SER SER HIS PRO ILE ALA LYS ALA ILE VAL LYS TYR ALA SEQRES 7 B 263 LYS GLU GLN GLY VAL LYS ILE LEU GLU VAL LYS ASP PHE SEQRES 8 B 263 LYS GLU ILE SER GLY ILE GLY VAL ARG GLY LYS ILE SER SEQRES 9 B 263 ASP LYS ILE ILE GLU VAL LYS LYS ALA GLU ASN ASN ASN SEQRES 10 B 263 ASP ILE ALA VAL TYR ILE ASN GLY GLU PRO ILE ALA SER SEQRES 11 B 263 PHE ASN ILE SER ASP VAL PRO ARG PRO ASN LEU LYS ASP SEQRES 12 B 263 TYR LEU GLU LYS LEU LYS ASN GLU GLY LEU LYS ILE ILE SEQRES 13 B 263 ILE LEU SER GLY ASP LYS GLU ASP LYS VAL LYS GLU LEU SEQRES 14 B 263 SER LYS GLU LEU ASN ILE GLN GLU TYR TYR SER ASN LEU SEQRES 15 B 263 SER PRO GLU ASP LYS VAL ARG ILE ILE GLU LYS LEU LYS SEQRES 16 B 263 GLN ASN GLY ASN LYS VAL LEU MET ILE GLY ASP GLY VAL SEQRES 17 B 263 ASN ASP ALA ALA ALA LEU ALA LEU ALA ASP VAL SER VAL SEQRES 18 B 263 ALA MET GLY ASN GLY VAL ASP ILE SER LYS ASN VAL ALA SEQRES 19 B 263 ASP ILE ILE LEU VAL SER ASN ASP ILE GLY THR LEU LEU SEQRES 20 B 263 GLY LEU ILE LYS ASN ARG LYS ARG LEU SER ASN ALA ILE SEQRES 21 B 263 PRO SER ASN HET AMP A1635 23 HET PO4 A1636 5 HET ATP B1636 31 HETNAM AMP ADENOSINE MONOPHOSPHATE HETNAM PO4 PHOSPHATE ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 3 AMP C10 H14 N5 O7 P FORMUL 4 PO4 O4 P 3- FORMUL 5 ATP C10 H16 N5 O13 P3 FORMUL 6 HOH *11(H2 O) HELIX 1 1 SER A 386 LYS A 394 1 9 HELIX 2 2 ASN A 402 GLU A 409 1 8 HELIX 3 3 ASP A 434 ALA A 446 1 13 HELIX 4 4 HIS A 450 GLY A 464 1 15 HELIX 5 5 LEU A 523 ASN A 532 1 10 HELIX 6 6 LYS A 544 ASN A 556 1 13 HELIX 7 7 SER A 565 ASN A 579 1 15 HELIX 8 8 GLY A 589 ASN A 591 5 3 HELIX 9 9 ASP A 592 ALA A 599 1 8 HELIX 10 10 VAL A 609 ASN A 614 1 6 HELIX 11 11 ASP A 624 LYS A 633 1 10 HELIX 12 12 SER B 386 LYS B 394 1 9 HELIX 13 13 ASN B 402 ILE B 410 1 9 HELIX 14 14 ASP B 434 ALA B 446 1 13 HELIX 15 15 HIS B 450 GLN B 463 1 14 HELIX 16 16 LEU B 523 GLU B 533 1 11 HELIX 17 17 LYS B 544 ASN B 556 1 13 HELIX 18 18 SER B 565 ASN B 579 1 15 HELIX 19 19 GLY B 589 ASN B 591 5 3 HELIX 20 20 ASP B 592 ALA B 599 1 8 HELIX 21 21 VAL B 609 ALA B 616 1 8 HELIX 22 22 ASP B 624 ASN B 634 1 11 SHEET 1 AA 7 ILE A 397 ILE A 398 0 SHEET 2 AA 7 ILE A 618 LEU A 620 -1 O ILE A 619 N ILE A 397 SHEET 3 AA 7 VAL A 601 MET A 605 1 O SER A 602 N ILE A 618 SHEET 4 AA 7 VAL A 583 GLY A 587 1 O VAL A 583 N VAL A 601 SHEET 5 AA 7 THR A 412 ASN A 416 1 O THR A 412 N LEU A 584 SHEET 6 AA 7 LYS A 536 LEU A 540 1 O LYS A 536 N ILE A 413 SHEET 7 AA 7 TYR A 560 TYR A 561 1 N TYR A 561 O ILE A 539 SHEET 1 AB 6 ILE A 427 ILE A 432 0 SHEET 2 AB 6 GLU A 508 SER A 516 -1 O SER A 512 N ILE A 432 SHEET 3 AB 6 ILE A 501 ILE A 505 -1 O ILE A 501 N PHE A 513 SHEET 4 AB 6 LYS A 488 LYS A 493 -1 O GLU A 491 N TYR A 504 SHEET 5 AB 6 GLY A 480 ILE A 485 -1 O VAL A 481 N VAL A 492 SHEET 6 AB 6 LYS A 471 GLU A 475 -1 O LYS A 471 N LYS A 484 SHEET 1 BA 7 MET B 396 ILE B 398 0 SHEET 2 BA 7 ILE B 618 LEU B 620 -1 O ILE B 619 N ILE B 397 SHEET 3 BA 7 VAL B 601 MET B 605 1 O SER B 602 N ILE B 618 SHEET 4 BA 7 VAL B 583 GLY B 587 1 O VAL B 583 N VAL B 601 SHEET 5 BA 7 THR B 412 ASN B 416 1 O THR B 412 N LEU B 584 SHEET 6 BA 7 LYS B 536 LEU B 540 1 O LYS B 536 N ILE B 413 SHEET 7 BA 7 GLU B 559 TYR B 561 1 O GLU B 559 N ILE B 539 SHEET 1 BB 6 ILE B 427 ILE B 432 0 SHEET 2 BB 6 GLU B 508 SER B 516 -1 O SER B 512 N ILE B 432 SHEET 3 BB 6 ILE B 501 ILE B 505 -1 O ILE B 501 N PHE B 513 SHEET 4 BB 6 LYS B 488 LYS B 494 -1 O GLU B 491 N TYR B 504 SHEET 5 BB 6 GLY B 480 ILE B 485 -1 O VAL B 481 N VAL B 492 SHEET 6 BB 6 LYS B 471 SER B 477 -1 O LYS B 471 N LYS B 484 SITE 1 AC1 8 GLU A 445 SER A 448 HIS A 450 GLY A 478 SITE 2 AC1 8 ILE A 479 VAL A 481 LYS A 494 ILE A 501 SITE 1 AC2 18 LYS B 417 THR B 418 GLU B 445 HIS B 450 SITE 2 AC2 18 ILE B 452 GLY B 478 ILE B 479 GLY B 480 SITE 3 AC2 18 VAL B 481 VAL B 492 LYS B 494 ILE B 501 SITE 4 AC2 18 SER B 541 GLY B 542 ASP B 543 LYS B 569 SITE 5 AC2 18 ASN B 591 ASP B 592 SITE 1 AC3 7 ASN A 416 LYS A 417 THR A 418 SER A 541 SITE 2 AC3 7 GLY A 542 LYS A 569 ASP A 592 CRYST1 52.120 75.150 133.920 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019186 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013307 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007467 0.00000